PRKCA and cancer: In this study, PKCα is considered an oncogene, but recent research has highlighted that PKCα overexpression leads to an enhanced rate of cancer cell death, probably by a mechanism in which PKCα inhibits β-catenin function, suggesting a tumor suppressor function for this kinase in CRC, where its expression is very low compared to normal tissue [65].